Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Am J Ophthalmol. 2009 Dec 30;149(3):496–502.e1. doi: 10.1016/j.ajo.2009.09.025

Table 2.

Retinal Thickness Analysis by Diabetic Status: Summary Data of Stratus OCT™ Parameters for Diabetic and Nondiabetic Patients

OCT Parameter Diabetic Nondiabetic P-Valuea
Centerpoint Foveal Thickness 157.8 ± 3.2 µm 156.9 ± 3.2 µm 0.86
Mean Foveal Thickness 191.6 ± 2.7 µm 194.5 ± 2.7 µm 0.49
Temporal Inner Macular 255.6 ± 1.9 µm 259.7 ± 2.4 µm 0.16
Superior Inner Macula 272.2 ± 2.1 µm 274.9 ± 2.1 µm 0.39
Nasal Inner Macula 269.3 ± 2.0 µm 273.3 ± 2.0 µm 0.18
Inferior Inner Macula 266.8 ± 2.0 µm 270.5 ± 2.5 µm 0.22
Temporal Outer Macula 221.0 ± 1.8 µm 222.7 ± 1.8 µm 0.54
Superior Outer Macula 240.7 ± 2.1 µm 242.3 ± 2.8 µm 0.64
Nasal Outer Macula 257.6 ± 2.2 µm 257.0 ± 2.2 µm 0.85
Inferior Outer Macula 230.3 ± 1.9 µm 229.3 ± 2.6 µm 0.75
Total Macular Volume 6.91 ± 0.06 mm3 6.81 ± 0.11 mm3 0.50
a

Generalized estimating equation (GEE), which adjusts for the correlation between eyes, was employed in the analyses. The Wald Chi-Square P-value is reported and means are given as least square mean ± se. All models are adjusted for race, gender, and age group (categorized by decades: 20’s, 30’s, 40’s,50’s, and 60+).